Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase III Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01012297
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:02.937015+00:00
Published At
2017-07-14T00:00:00+00:00
Record Updated At
2020-09-02
Results Posted At
2017-07-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Uterine Corpus Sarcoma", "Stage IIIA Uterine Sarcoma", "Stage IIIB Uterine Sarcoma", "Stage IIIC Uterine Sarcoma", "Stage IVA Uterine Sarcoma", "Stage IVB Uterine Sarcoma", "Uterine Corpus Leiomyosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-02"
protocolSection.identificationModule.nctId
"NCT01012297"
protocolSection.identificationModule.officialTitle
"A Randomized Phase III Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-07-14"

Study condition terms

  • Recurrent Uterine Corpus Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Uterine Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage IIIB Uterine Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage IIIC Uterine Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Uterine Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Uterine Sarcoma (protocolSection.conditionsModule.conditions)
  • Uterine Corpus Leiomyosarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.